<iframe src="//www.googletagmanager.com/ns.html?id=GTM-PFR3SFR" height="0" width="0" style="display:none;visibility:hidden">

Longevity: How science is extending healthspans

Jun 10, 2024 | RBC Wealth Management


Share

Amid an innovation revolution in biotech that stands to not only transform our lives but also impact investment portfolios, what should investors be looking for?

Innovations web feature image

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      This video is part of the “Innovations” series exploring new technological advancements and how these agents of change can open up compelling investment opportunities.

      The video features Dr. Brian Abrahams, Head of Global Healthcare Research for RBC Capital Markets, and Frédérique Carrier, Head of Investment Strategy in the British Isles and Asia for RBC Wealth Management, as they talk about biotech innovations related to longevity and how investors can approach this theme.

      Brian and Frédérique discuss:

      • Some of the most promising biotech innovations that may improve healthspans
      • What investors should look for when investing in the biotech sector
      • Some of the most topical disruptive forces in biotech
      • How AI is changing the sector’s opportunity set

      Categories

      Analysis

      Let's start the conversation

      If you'd like to discuss anything in more detail, please reach out here:
      Contact Us
      Disclosures

      This recording is provided by RBC Wealth Management for informational purposes only. In Canada, RBC Wealth Management is the brand name that refers to RBC Dominion Securities, Inc., and applicable affiliates. In the United States, RBC Wealth Management is a division of RBC Capital Markets, LLC. In the United Kingdom and Channel Islands, RBC's Wealth Management International division in these jurisdictions is comprised of an international network of RBC companies and includes RBC Europe Limited and Royal Bank of Canada (Channel Islands) Limited. In Asia, RBC Wealth Management is the global brand name to describe the wealth management business of the Royal Bank of Canada and its affiliates and branches, including Royal Bank of Canada Singapore branch and Royal Bank of Canada Hong Kong branch.

      The comments contained in this recording are general in nature, do not have regard to the particular circumstances or needs of any specific person, and do not constitute legal, investment, trust, estate, accounting, or tax advice. Unless otherwise qualified, any opinions, estimates, and projections in this recording are those of the speakers as of the release date, are subject to change without notice, and may not reflect those of RBC Wealth Management. This recording may not reflect all available information. The investments or services contained in this recording may not be suitable for you, and it is recommended you consult with your Advisor if you are in doubt about the suitability of such investments or services. In Canada, to obtain additional disclaimers concerning this recording, please speak with your Advisor.

      Rob Caiaze, NMLS # 63846, Adam Reed, NMLS # 64647, and Luke Violette, NMLS # 2335097 through City National Bank, may receive compensation from RBC Wealth Management for referring customers to City National Bank. Banking products and services are offered or issued by City National Bank, an affiliate of RBC Wealth Management, a division of RBC Capital Markets, LLC, Member NYSE/FINRA/SIPC and are subject to City National Banks terms and conditions. Products and services offered through City National Bank are not insured by SIPC. City National Bank Member FDIC.

      Investment products offered through RBC Wealth Management are not FDIC insured, are not guaranteed by City National Bank and may lose value.